[1]
Christine Feng, DO, PGY3, Pavel Kibrik, DO, Christian Castañeda, MD, and Gurdeep Singh, MD, FACE, “New-Onset Diabetic Ketoacidosis Secondary to Nivolumab Therapy in a Patient with Primary Central Nervous System Lymphoma”, OFP, vol. 13, no. 3, pp. 40–43, May 2021.